logo
Johnson Controls Reports Strong Q2 Results; Raises FY25 Guidance

Johnson Controls Reports Strong Q2 Results; Raises FY25 Guidance

Yahoo07-05-2025

Sales in the quarter of $2.9 billion increased 6% over the prior year. Organic sales increased 7% over the prior year, led by continued strength across Applied HVAC and Controls.
A slide presentation to accompany the results can be found in the Investor Relations section of Johnson Controls' website at http://investors.johnsoncontrols.com .
The financial highlights presented in the tables below exclude discontinued operations and are in accordance with GAAP, unless otherwise indicated. All comparisons are to the second quarter of fiscal 2024.
"The Johnson Controls team delivered strong second quarter results, highlighted by organic sales growth, margin expansion and record backlog," said Joakim Weidemanis, CEO. "The results reflect the strengthened execution from our team as well as broad-based and sustained demand for our differentiated solutions. We have a strong foundation in place and by starting to increase customer focus and implement lean and business system approaches, we can take the first step to accelerate our momentum and enhance value for all of our stakeholders."
Sales in the quarter of $5.7 billion increased 1% over the prior year on an as reported basis and 7% organically. GAAP income from continuing operations was $473 million. Adjusted income from continuing operations was $545 million.
CORK, Ireland, May 7, 2025 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), a global leader for smart, safe, healthy and sustainable buildings, today reported fiscal second quarter 2025 GAAP earnings per share ("EPS") of $0.71. Adjusted EPS was $0.82.
* This news release contains non-GAAP financial measures. Definitions and reconciliations of the non-GAAP financial measures can be found in the attached footnotes. Non-GAAP measures should be considered in addition to, and not as replacements for, the most comparable GAAP measures.
Story Continues
Excluding M&A and adjusted for foreign currency, orders increased 4% year-over-year and backlog of $9.8 billion increased 11% year-over-year.
Segment EBITA margin of 13.4% declined 20 basis points versus the prior year as Systems growth outpaced Service growth.
Building Solutions EMEA/LA (Europe, Middle East, Africa/Latin America)
Fiscal Q2
(in millions)
2025
2024
Change
Sales
$ 1,085
$ 1,064
2 %
Segment EBITA
GAAP
136
89
53 %
Adjusted (non-GAAP)
136
89
53 %
Segment EBITA Margin %
GAAP
12.5 %
8.4 %
410 bp
Adjusted (non-GAAP)
12.5 %
8.4 %
410 bp
Sales in the quarter of $1.1 billion increased 2% over the prior year. Organic sales grew 5% versus the prior year quarter led by 9% growth in Service, including solid growth in Applied HVAC and Fire and Security sales.
Excluding M&A and adjusted for foreign currency, orders increased 10% year-over-year and backlog of $2.7 billion increased 10% year-over-year.
Segment EBITA margin of 12.5% expanded 410 basis points versus the prior year driven by productivity improvements and positive mix from growth in Service.
Building Solutions Asia Pacific
Fiscal Q2
(in millions)
2025
2024
Change
Sales
$ 542
$ 491
10 %
Segment EBITA
GAAP
79
54
46 %
Adjusted (non-GAAP)
79
54
46 %
Segment EBITA Margin %
GAAP
14.6 %
11.0 %
360 bp
Adjusted (non-GAAP)
14.6 %
11.0 %
360 bp
Sales in the quarter of $542 million increased 10% versus the prior year. Organic sales increased 13% versus the prior year led by strong double-digit growth from both Service and Systems.
Excluding M&A and adjusted for foreign currency, orders were flat year-over-year and backlog of $1.5 billion increased 21% year-over-year.
Segment EBITA margin of 14.6% increased 360 basis points versus the prior year driven by productivity improvements.
Global Products
Fiscal Q2
(in millions)
2025
2024
Change
Sales
$ 1,133
$ 1,303
(13 %)
Segment EBITA
GAAP
341
290
18 %
Adjusted (non-GAAP)
343
316
9 %
Segment EBITA Margin %
GAAP
30.1 %
22.3 %
780 bp
Adjusted (non-GAAP)
30.3 %
24.3 %
600 bp
Sales in the quarter of $1.1 billion declined 13% versus the prior year. Organic sales grew 8% versus the prior year, led by positive price and volume growth. Excluding the impact of divestitures, Applied HVAC grew over 20% with strong double-digit growth in North America and EMEA/LA.
Segment EBITA margin of 30.1% expanded 780 basis points versus the prior year due to enhanced operational efficiencies and increased volumes, excluding the impact of divestitures. Adjusted segment EBITA in Q2 2025 excludes transformation costs. Adjusted segment EBITA in Q2 2024 excludes costs for a product quality issue, partially offset by favorable earn-out adjustments.
Corporate
Fiscal Q2
(in millions)
2025
2024
Change
Corporate Expense
GAAP
$ 186
$ 92
102 %
Adjusted (non-GAAP)
135
83
63 %
Corporate expenses increased over the prior year as a result of certain corporate accruals combined with the impact of stranded costs from the planned divestiture of the R&LC HVAC business. Adjusted Corporate expense in Q2 2025 excludes certain transaction/separation costs and transformation costs. Adjusted Corporate expense in Q2 2024 excludes certain transaction/separation costs and cyber incident costs.
OTHER Q2 ITEMS
Cash provided by operating activities was $550 million. Free cash flow was $456 million and adjusted free cash flow was $463 million.
The Company paid dividends of $245 million.
The Company repurchased 4.1 million shares of common stock for $330 million.
GUIDANCE
The following forward-looking statements regarding organic sales growth, adjusted segment EBITA margin, adjusted segment EBITA margin improvement, adjusted EPS and adjusted free cash flow conversion are non-GAAP financial measures and are presented on a continuing operations basis excluding the Residential and Light Commercial HVAC business, which was classified as discontinued operations beginning in the fiscal fourth quarter of 2024. These non-GAAP financial measures are derived by excluding certain amounts from the corresponding financial measures determined in accordance with GAAP. The determination of the amounts excluded is a matter of management judgment and depends upon, among other factors, the nature of the underlying expense or income amounts recognized in a given period and the high variability of certain amounts, such as mark-to-market adjustments. Organic revenue growth excludes the effect of acquisitions, divestitures and foreign currency. The Company is unable to present a quantitative reconciliation of the aforementioned forward-looking non-GAAP financial measures to its most directly comparable forward-looking GAAP financial measures because such information is not available, and management cannot reliably predict the necessary components of such GAAP measures without unreasonable effort or expense. The unavailable information could have a significant impact on the Company's fiscal 2025 third quarter and full year GAAP financial results from continuing operations.
The Company initiated fiscal 2025 third quarter guidance:
Organic sales growth of mid-single digits
Adjusted segment EBITA margin of ~17.5%
Adjusted EPS before special items of ~$0.97 to $1.00
The Company raised fiscal 2025 full year guidance:
Organic sales growth of mid-single digits (unchanged)
Adjusted segment EBITA margin improvement of ~90 basis points year-over-year (previously more than 80 bps)
Adjusted EPS before special items of ~$3.60 (previously ~$3.50 to $3.60)
Adjusted free cash flow conversion of ~100% (previously ~90%+)
CONFERENCE CALL & WEBCAST INFO
Johnson Controls will host a conference call to discuss this quarter's results at 8:30 a.m. ET today, which can be accessed by dialing 844-763-8274 (in the United States) or +1-412-717-9224 (outside the United States), or via webcast. A slide presentation will accompany the prepared remarks and has been posted on the investor relations section of the Johnson Controls website at https://investors.johnsoncontrols.com/news-and-events/events-and-presentations. A replay will be made available approximately two hours following the conclusion of the conference call.
ABOUT JOHNSON CONTROLS
At Johnson Controls (NYSE:JCI), we transform the environments where people live, work, learn and play. As the global leader in smart, healthy and sustainable buildings, our mission is to reimagine the performance of buildings to serve people, places and the planet.
Building on a proud history of nearly 140 years of innovation, we deliver the blueprint of the future for industries such as healthcare, schools, data centers, airports, stadiums, manufacturing and beyond through OpenBlue, our comprehensive digital offering.
Today, Johnson Controls offers the world`s largest portfolio of building technology and software as well as service solutions from some of the most trusted names in the industry.
Visit www.johnsoncontrols.com for more information and follow @Johnson Controls on social platforms.
JOHNSON CONTROLS CONTACTS:
INVESTOR CONTACTS:
MEDIA CONTACT:
Jim Lucas
Danielle Canzanella
Direct: +1 414.340.1752
Direct: +1 203.499.8297
Email: jim.lucas@jci.com
Email: danielle.canzanella@jci.com
Michael Gates
Direct: +1 414.524.5785
Email: michael.j.gates@jci.com
JOHNSON CONTROLS INTERNATIONAL PLC CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Johnson Controls International plc has made statements in this communication that are forward-looking and therefore are subject to risks and uncertainties. All statements in this document other than statements of historical fact are, or could be, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. In this communication, statements regarding Johnson Controls' future financial position, sales, costs, earnings, cash flows, other measures of results of operations, synergies and integration opportunities, capital expenditures, debt levels and market outlook are forward-looking statements. Words such as "may," "will," "expect," "intend," "estimate," "anticipate," "believe," "should," "forecast," "project" or "plan" and terms of similar meaning are also generally intended to identify forward-looking statements. However, the absence of these words does not mean that a statement is not forward-looking. Johnson Controls cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond its control, that could cause its actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks related to: Johnson Controls' ability to manage macroeconomic and geopolitical volatility, including changes to laws or policies governing foreign trade, including tariffs, economic sanctions, foreign exchange and capital controls, import/export controls or other trade restrictions as well as supply chain disruptions; the ability of Johnson Controls to manage general economic, business and capital market conditions, including the impacts of trade restrictions, recessions, economic downturns and global price inflation; Johnson Controls' ability to develop or acquire new products and technologies that achieve market acceptance and meet applicable quality and regulatory requirements; the ability of Johnson Controls to execute on its operating model and drive organizational improvement; Johnson Controls' ability to successfully execute and complete portfolio simplification, including the completion of the divestiture of the Residential and Light Commercial business, as well as the possibility that the expected benefits of such actions will not be realized or will not be realized within the expected time frame; the ability to hire and retain senior management and other key personnel, including successfully completing Johnson Controls' Chief Executive Officer transition; the ability to innovate and adapt to emerging technologies, ideas and trends in the marketplace, including the incorporation of technologies such as artificial intelligence; fluctuations in the cost and availability of public and private financing for Johnson Controls' customers; the ability to manage disruptions caused by international conflicts, including Russia and Ukraine and the ongoing conflicts in the Middle East; managing the risks and impacts of potential and actual security breaches, cyberattacks, privacy breaches or data breaches, maintaining and improving the capacity, reliability and security of Johnson Controls' enterprise information technology infrastructure; the ability to manage the lifecycle cybersecurity risk in the development, deployment and operation of Johnson Controls' digital platforms and services; fluctuations in currency exchange rates; changes or uncertainty in laws, regulations, rates, policies, or interpretations that impact Johnson Controls' business operations or tax status; the ability to adapt to global climate change, climate change regulation and successfully meet Johnson Controls' public sustainability commitments; the outcome of litigation and governmental proceedings; the risk of infringement or expiration of intellectual property rights; Johnson Controls' ability to manage disruptions caused by catastrophic or geopolitical events, such as natural disasters, armed conflict, political change, climate change, pandemics and outbreaks of contagious diseases and other adverse public health developments; any delay or inability of Johnson Controls to realize the expected benefits and synergies of recent portfolio transactions; the tax treatment of recent portfolio transactions; significant transaction costs and/or unknown liabilities associated with such transactions; labor shortages, work stoppages, union negotiations, labor disputes and other matters associated with the labor force; and the cancellation of or changes to commercial arrangements. A detailed discussion of risks related to Johnson Controls' business is included in the section entitled "Risk Factors" in Johnson Controls Annual Report on Form 10-K for the fiscal year ended September 30, 2024 filed with the SEC on November 19, 2024, which is available at www.sec.gov and www.johnsoncontrols.com under the "Investors" tab. The description of certain of these risks is supplemented in Item 1A of Part II of Johnson Controls subsequently filed Quarterly Reports on Form 10-Q. Shareholders, potential investors and others should consider these factors in evaluating the forward-looking statements and should not place undue reliance on such statements. The forward-looking statements included in this communication are made only as of the date of this document, unless otherwise specified, and, except as required by law, Johnson Controls assumes no obligation, and disclaims any obligation, to update such statements to reflect events or circumstances occurring after the date of this communication.
FINANCIAL STATEMENTS
Johnson Controls International plc
Consolidated Statements of Income
(in millions, except per share data; unaudited)
Three Months Ended
March 31,
Six Months Ended
March 31,
2025
2024
2025
2024
Net sales
Products and systems
$ 3,865
$ 3,883
$ 7,550
$ 7,487
Services
1,811
1,714
3,552
3,319
5,676
5,597
11,102
10,806
Cost of sales
Products and systems
2,523
2,616
4,979
5,107
Services
1,084
1,059
2,128
1,999
3,607
3,675
7,107
7,106
Gross profit
2,069
1,922
3,995
3,700
Selling, general and administrative expenses
1,427
2,064
2,826
3,398
Restructuring and impairment costs
62
239
95
274
Net financing charges
80
89
166
176
Equity income (loss)
1
(1)
1
(3)
Income (loss) from continuing operations before income taxes
501
(471)
909
(151)
Income tax provision (benefit)
26
(153)
73
(173)
Income (loss) from continuing operations
475
(318)
836
22
Income from discontinued operations, net of tax
51
84
141
148
Net income (loss)
526
(234)
977
170
Income (loss) attributable to noncontrolling interests
Continuing operations
2
3

3
Discontinued operations
46
40
80
70
Net income (loss) attributable to Johnson Controls
$ 478
$ (277)
$ 897
$ 97
Income (loss) attributable to Johnson Controls
Continuing operations
$ 473
$ (321)
$ 836
$ 19
Discontinued operations
5
44
61
78
Total
$ 478
$ (277)
$ 897
$ 97
Basic earnings (loss) per share attributable to Johnson Controls
Continuing operations
$ 0.72
$ (0.47)
$ 1.27
$ 0.03
Discontinued operations
0.01
0.06
0.09
0.11
Total
$ 0.73
$ (0.41)
$ 1.36
$ 0.14
Diluted earnings (loss) per share attributable to Johnson Controls
Continuing operations
$ 0.71
$ (0.47)
1.26
0.03
Discontinued operations
0.01
0.06
0.09
0.11
Total
$ 0.72
$ (0.41)
$ 1.35
$ 0.14
Johnson Controls International plc
Condensed Consolidated Statements of Financial Position
(in millions; unaudited)
March 31, 2025
September 30, 2024
Assets
Cash and cash equivalents
$ 795
$ 606
Accounts receivable - net
5,858
6,051
Inventories
1,756
1,774
Current assets held for sale
1,856
1,595
Other current assets
1,085
1,153
Current assets
11,350
11,179
Property, plant and equipment - net
2,422
2,403
Goodwill
16,509
16,725
Other intangible assets - net
3,883
4,130
Noncurrent assets held for sale
3,101
3,210
Other noncurrent assets
5,102
5,048
Total assets
$ 42,367
$ 42,695
Liabilities and Equity
Short-term debt
$ 1,261
$ 953
Current portion of long-term debt
558
536
Accounts payable
3,254
3,389
Accrued compensation and benefits
832
1,048
Deferred revenue
2,380
2,160
Current liabilities held for sale
1,544
1,431
Other current liabilities
1,988
2,438
Current liabilities
11,817
11,955
Long-term debt
8,167
8,004
Pension and postretirement benefit obligations
181
217
Noncurrent liabilities held for sale
429
405
Other noncurrent liabilities
4,741
4,753
Long-term liabilities
13,518
13,379
Shareholders' equity attributable to Johnson Controls
15,805
16,098
Noncontrolling interests
1,227
1,263
Total equity
17,032
17,361
Total liabilities and equity
$ 42,367
$ 42,695
Consolidated Statements of Cash Flows
(in millions; unaudited)
Three Months
Ended March 31,
Six Months Ended
March 31,
2025
2024
2025
2024
Operating Activities of Continuing Operations
Income (loss) from continuing operations attributable to Johnson Controls
$ 473
$ (321)
$ 836
$ 19
Income from continuing operations attributable to noncontrolling interests
2
3

3
Income (loss) from continuing operations
475
(318)
836
22
Adjustments to reconcile net income to cash provided (used) by operating activities:
Depreciation and amortization
202
215
395
423
Pension and postretirement income and contributions
(21)
(15)
(37)
(31)
Deferred income taxes
(53)
(339)
(107)
(419)
Noncash restructuring and impairment charges
25
244
33
253
Equity-based compensation
31
25
59
54
Other - net
24
(15)
32
(37)
Changes in assets and liabilities:
Accounts receivable
(191)
(549)
93
(509)
Inventories
(12)
(29)
(27)
(135)
Other assets
(42)
5
(213)
(190)
Restructuring reserves
(5)
(46)
(3)
(60)
Accounts payable and accrued liabilities
180
517
(227)
202
Accrued income taxes
(63)
(21)
(35)
(10)
Cash provided (used) by operating activities from continuing operations
550
(326)
799
(437)
Investing Activities of Continuing Operations
Capital expenditures
(94)
(128)
(210)
(210)
Other - net
(18)
(4)
(7)
14
Cash used by investing activities from continuing operations
(112)
(132)
(217)
(196)
Financing Activities of Continuing Operations
Net proceeds from borrowings with maturities less than three months
346
427
358
1,543
Proceeds from debt


775
422
Repayments of debt
(502)
(163)
(502)
(163)
Stock repurchases and retirements
(330)
(474)
(660)
(474)
Payment of cash dividends
(245)
(252)
(490)
(504)
Proceeds from the exercise of stock options
61
8
105
20
Employee equity-based compensation withholding taxes
(2)
(1)
(31)
(24)
Other - net
(3)
(41)
(29)
(80)
Cash provided (used) by financing activities from continuing operations
(675)
(496)
(474)
740
Discontinued Operations
Cash provided (used) by operating activities
49
123
47
(12)
Cash used by investing activities
(17)
(5)
(27)
(15)
Cash used by financing activities
(65)
(55)
(65)
(63)
Cash provided (used) by discontinued operations
(33)
63
(45)
(90)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(169)
(41)
(15)
19
Change in cash, cash equivalents and restricted cash held for sale
(1)
(4)
3
1
Increase (decrease) in cash, cash equivalents and restricted cash
(440)
(936)
51
37
Cash, cash equivalents and restricted cash at beginning of period
1,258
1,890
767
917
Cash, cash equivalents and restricted cash at end of period
818
954
818
954
Less: Restricted cash
23
116
23
116
Cash and cash equivalents at end of period
$ 795
$ 838
$ 795
$ 838
FOOTNOTES
1. Sale of Residential and Light Commercial HVAC Business
The Company signed a definitive agreement in July 2024 to sell its Residential and Light Commercial ("R&LC") HVAC business, which includes the North America Ducted businesses and the global Residential joint venture with Hitachi Global Life Solutions, Inc. ("Hitachi"), of which Johnson Controls owns 60% and Hitachi owns 40%. The R&LC HVAC business, which was previously reported in the Global Products segment, meets the criteria to be classified as a discontinued operation and, as a result, its historical financial results are reflected in the consolidated financial statements as a discontinued operation, and assets and liabilities were reclassified as held for sale for all periods presented. Unless otherwise noted, all activities and amounts reported in the following footnotes include only continuing operations of the Company and exclude activities and amounts related to the R&LC HVAC business.
2. Non-GAAP Measures
The Company reports various non-GAAP measures in this earnings release and the related earnings presentation. Non-GAAP measures should be considered in addition to, and not as replacements for, the most comparable GAAP measures. Refer to footnotes three through eight for further information on the calculations of the non-GAAP measures and reconciliations of the non-GAAP measures to the most comparable GAAP measures.
Organic sales
Organic sales growth excludes the impact of acquisitions, divestitures and foreign currency. Management believes organic sales growth is useful to investors in understanding period-over-period sales results and trends.
Cash flow
Management believes free cash flow and adjusted free cash flow measures are useful to investors in understanding the strength of the Company and its ability to generate cash. These non-GAAP measures can also be used to evaluate the Company's ability to generate cash flow from operations and the impact that this cash flow has on its liquidity. Management also believes adjusted free cash flows are useful to investors in understanding period-over-period cash flows, cash trends and ongoing cash flows of the Company.
Adjusted free cash flow and adjusted free cash flow conversion are non-GAAP measures which exclude the impacts of the following:
JC Capital cash flows primarily include activity associated with finance/notes receivables and inventory and/or capital expenditures related to lease arrangements. JC Capital net income is primarily related to interest income on the finance/notes receivable and profit recognized on arrangements with sales-type lease components.
Effective January 1, 2024, the Company has excluded the impact of discontinuing its accounts receivables factoring programs from adjusted free cash flow and adjusted free cash flow conversion. The Company has also re-baselined the prior year adjusted free cash flow measures to present a more comparative measure without the impact of factoring.
Cash payments related to the water systems AFFF settlement and cash receipts for AFFF-related insurance recoveries.
Adjusted financial measures
Adjusted financial measures include adjusted segment EBITA, adjusted segment EBITA margin, adjusted net income, adjusted earnings per share, adjusted EBIT, adjusted EBITDA and adjusted corporate expenses. These non-GAAP measures are derived by excluding certain amounts from the corresponding financial measures determined in accordance with GAAP. The determination of the excluded amounts is a matter of management judgment and depends upon the nature and variability of the underlying expense or income amounts and other factors.
As detailed in the tables included in footnotes five through eight, the following items were excluded from certain financial measures:
Net mark-to-market adjustments are the result of adjusting restricted asbestos investments and pension and postretirement plan assets to their current market value. These adjustments may have a favorable or unfavorable impact on results.
Restructuring and impairment costs, net of NCI represents restructuring costs attributable to Johnson Controls including costs associated with exit plans or other restructuring plans that will have a more significant impact on the underlying cost structure of the organization. Impairment costs primarily relate to write-downs of goodwill, intangible assets and assets held for sale to their fair value.
Water systems AFFF settlement and insurance recoveries include amounts related to a settlement with a nationwide class of public water systems concerning the use of AFFF manufactured and sold by a subsidiary of the Company, and AFFF-related insurance recoveries.
Transaction/separation costs include costs associated with significant mergers and acquisitions.
Transformation costs represent incremental expenses incurred in association with strategic growth initiatives and cost saving opportunities in order to realize the benefits of portfolio simplification and the Company's lifecycle solutions strategy.
Earn-out adjustments relate to earn-out liabilities associated with certain significant acquisitions and may have a favorable or unfavorable impact on results.
Cyber incident costs primarily represent expenses, net of insurance recoveries, associated with the response to, and remediation of, a cybersecurity incident which occurred in September 2023.
Global Products product quality costs are costs related to a product quality issue within the Global Products segment that is unusual due to the magnitude of the expected cost to remediate in comparison to typical product quality issues experienced by the Company.
Loss on divestiture relates to the sale of the ADTi business.
EMEA/LA joint venture loss relates to certain non-recurring losses associated with the equity method accounting of a joint venture company.
Discrete tax items, net includes the net impact of discrete tax items within the period, including the following types of items: changes in estimates associated with valuation allowances, changes in estimates associated with reserves for uncertain tax positions, withholding taxes recorded upon changes in indefinite re-investment assertions for businesses to be disposed of, impacts from statutory rate changes, and the recording of significant tax credits.
Related tax impact includes the tax impact of the various excluded items.
Management believes the exclusion of these items is useful to investors due to the unusual nature and/or magnitude of the amounts. When considered together with unadjusted amounts, adjusted financial measures are useful to investors in understanding period-over-period operating results, business trends and ongoing operations of the Company. Management may also use these metrics as guides in forecasting, budgeting and long-term planning processes and for compensation purposes.
Debt ratios
Management believes that net debt to adjusted EBITDA, a non-GAAP measure, is useful to understanding the Company's financial condition as the ratio provides an overview of the extent to which the Company relies on external debt financing for its funding and also is a measure of risk to its shareholders.
3. Sales
The following tables detail the changes in sales from continuing operations attributable to organic growth, foreign currency, acquisitions, divestitures and other (unaudited):
Three Months Ended March 31
Net sales
Building Solutions
(in millions)
North
America
EMEA/LA
Asia
Pacific
Total
Global
Products
Total JCI
plc
Net sales - 2024
$ 2,739
$ 1,064
$ 491
$ 4,294
$ 1,303
$ 5,597
Base year adjustments
Divestitures and other




(242)
(242)
Foreign currency
(10)
(36)
(11)
(57)
(12)
(69)
Adjusted base net sales
2,729
1,028
480
4,237
1,049
5,286
Acquisitions

9

9

9
Organic growth
187
48
62
297
84
381
Net sales - 2025
$ 2,916
$ 1,085
$ 542
$ 4,543
$ 1,133
$ 5,676
Growth %:
Net sales
6 %
2 %
10 %
6 %
(13) %
1 %
Organic growth
7 %
5 %
13 %
7 %
8 %
7 %
Six Months Ended March 31
Net sales
Building Solutions
(in millions)
North
America
EMEA/LA
Asia
Pacific
Total
Global
Products
Total JCI
plc
Net sales - 2024
$ 5,226
$ 2,102
$ 998
$ 8,326
$ 2,480
$ 10,806
Base year adjustments
Divestitures and other




(475)
(475)
Foreign currency
(13)
(61)
(14)
(88)
(14)
(102)
Adjusted base net sales
5,213
2,041
984
8,238
1,991
10,229
Acquisitions

12

12

12
Organic growth
447
105
85
637
224
861
Net sales - 2025
$ 5,660
$ 2,158
$ 1,069
$ 8,887
$ 2,215
$ 11,102
Growth %:
Net sales
8 %
3 %
7 %
7 %
(11) %
3 %
Organic growth
9 %
5 %
9 %
8 %
11 %
8 %
Three Months Ended March 31
Products and systems revenue
Building Solutions
(in millions)
North
America
EMEA/LA
Asia
Pacific
Total
Global
Products
Total JCI
plc
Products and systems revenue - 2024
$ 1,700
$ 572
$ 308
$ 2,580
$ 1,303
$ 3,883
Base year adjustments
Divestitures and other




(242)
(242)
Foreign currency
(5)
(20)
(7)
(32)
(12)
(44)
Adjusted products and systems revenue
1,695
552
301
2,548
1,049
3,597
Acquisitions

7

7

7
Organic growth
135
6
36
177
84
261
Products and systems revenue - 2025
$ 1,830
$ 565
$ 337
$ 2,732
$ 1,133
$ 3,865
Growth %:
Products and systems revenue
8 %
(1) %
9 %
6 %
(13) %
— %
Organic growth
8 %
1 %
12 %
7 %
8 %
7 %
Six Months Ended March 31
Products and systems revenue
Building Solutions
(in millions)
North
America
EMEA/LA
Asia
Pacific
Total
Global
Products
Total JCI
plc
Products and systems revenue - 2024
$ 3,218
$ 1,144
$ 645
$ 5,007
$ 2,480
$ 7,487
Base year adjustments
Divestitures and other




(475)
(475)
Foreign currency
(5)
(32)
(10)
(47)
(14)
(61)
Adjusted products and systems revenue
3,213
1,112
635
4,960
1,991
6,951
Acquisitions

9

9

9
Organic growth
311
19
36
366
224
590
Products and systems revenue - 2025
$ 3,524
$ 1,140
$ 671
$ 5,335
$ 2,215
$ 7,550
Growth %:
Products and systems revenue
10 %
— %
4 %
7 %
(11) %
1 %
Organic growth
10 %
2 %
6 %
7 %
11 %
8 %
Three Months Ended March 31
Service revenue
Building Solutions
(in millions)
North
America
EMEA/LA
Asia
Pacific
Total
Global
Products
Total JCI
plc
Service revenue - 2024
$ 1,039
$ 492
$ 183
$ 1,714
$ —
$ 1,714
Base year adjustments
Divestitures and other






Foreign currency
(5)
(16)
(4)
(25)

(25)
Adjusted base service revenue
1,034
476
179
1,689

1,689
Acquisitions

2

2

2
Organic growth
52
42
26
120

120
Service revenue - 2025
$ 1,086
$ 520
$ 205
$ 1,811
$ —
$ 1,811
Growth %:
Service revenue
5 %
6 %
12 %
6 %
— %
6 %
Organic growth
5 %
9 %
15 %
7 %
— %
7 %
Six Months Ended March 31
Service revenue
Building Solutions
(in millions)
North
America
EMEA/LA
Asia
Pacific
Total
Global
Products
Total JCI
plc
Service revenue - 2024
$ 2,008
$ 958
$ 353
$ 3,319
$ —
$ 3,319
Base year adjustments
Divestitures and other






Foreign currency
(8)
(29)
(4)
(41)

(41)
Adjusted base service revenue
2,000
929
349
3,278

3,278
Acquisitions

3

3

3
Organic growth
136
86
49
271

271
Service revenue - 2025
$ 2,136
$ 1,018
$ 398
$ 3,552
$ —
$ 3,552
Growth %:
Service revenue
6 %
6 %
13 %
7 %
— %
7 %
Organic growth
7 %
9 %
14 %
8 %
— %
8 %
4. Cash Flow, Free Cash Flow and Free Cash Flow Conversion
The following table includes operating cash flow conversion, free cash flow and free cash flow conversion (unaudited):
Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)
2025
2024
2025
2024
Cash provided (used) by operating activities from continuing operations
$ 550
$ (326)
$ 799
$ (437)
Income (loss) from continuing operations attributable to Johnson Controls
473
(321)
836
19
Operating cash flow conversion
116 %
*
96 %
*
Cash provided (used) by operating activities from continuing operations
550
(326)
799
(437)
Capital expenditures
(94)
(128)
(210)
(210)
Free cash flow (non-GAAP)
$ 456
$ (454)
$ 589
$ (647)
Income (loss) from continuing operations attributable to Johnson Controls
473
(321)
836
19
Free cash flow conversion from net income (non-GAAP)
96 %
*
70 %
*
* Measure not meaningful
The following table includes adjusted free cash flow and adjusted free cash flow conversion (unaudited):
Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions)
2025
2024
2025
2024
Free cash flow (non-GAAP)
$ 456
$ (454)
$ 589
$ (647)
Adjustments:
JC Capital cash used by operating activities
11
32
77
120
Water systems AFFF settlement cash payments and insurance
recoveries
(11)

386

Impact from discontinuation of factoring programs
7

14

Adjusted free cash flow (non-GAAP)
463
(422)
1,066
(527)
Prior year impact from factoring programs

619

534
Re-baselined adjusted free cash flow (non-GAAP)
$ 463
$ 197
$ 1,066
$ 7
Adjusted net income attributable to JCI (non-GAAP)
$ 545
$ 471
$ 971
$ 786
JC Capital net income (loss)
9
(3)
4
(5)
Adjusted net income attributable to JCI, excluding JC Capital (non-
GAAP)
$ 554
$ 468
$ 975
$ 781
Adjusted free cash flow conversion (non-GAAP)
84 %
42 %
109 %
1 %
5. EBITA, EBIT and Corporate Expense
The Company evaluates the performance of its business units primarily on segment EBITA. The following table includes continuing operations (unaudited):
Three Months Ended March 31,
Six Months Ended March 31,
Actual
Adjusted
(Non-GAAP)
Actual
Adjusted
(Non-GAAP)
(in millions)
2025
2024
2025
2024
2025
2024
2025
2024
Segment EBITA
Building Solutions North America
$ 390
$ 373
$ 390
$ 373
$ 722
$ 658
$ 722
$ 658
Building Solutions EMEA/LA
136
89
136
89
244
169
244
169
Building Solutions Asia Pacific
79
54
79
54
128
100
128
100
Global Products
341
290
343
316
667
557
669
583
EBIT (non-GAAP)
Income (loss) from continuing operations:
Attributable to Johnson Controls
$ 473
$ (321)
$ 545
$ 471
$ 836
$ 19
$ 971
$ 786
Attributable to noncontrolling interests
2
3
2
3

3

3
Income (loss) from continuing operations
475
(318)
547
474
836
22
971
789
Less: Income tax provision (benefit) (1)
26
(153)
74
64
73
(173)
132
105
Income (loss) before income taxes
501
(471)
621
538
909
(151)
1,103
894
Net financing charges
80
89
80
89
166
176
166
176
EBIT (non-GAAP)
$ 581
$ (382)
$ 701
$ 627
$ 1,075
$ 25
$ 1,269
$ 1,070
(1) Adjusted income tax provision (benefit) excludes the related tax impacts of pre-tax adjusting items.
The following tables include the reconciliations of segment EBITA as reported to adjusted segment EBITA and adjusted segment EBITA margin (unaudited):
Three Months Ended March 31,
(in millions)
Building Solutions
North America
Building Solutions
EMEA/LA
Building Solutions
Asia Pacific
Global Products
2025
2024
2025
2024
2025
2024
2025
2024
Sales
$ 2,916
$ 2,739
$ 1,085
$ 1,064
$ 542
$ 491
$ 1,133
$ 1,303
Segment EBITA
$ 390
$ 373
$ 136
$ 89
$ 79
$ 54
$ 341
$ 290
Adjusting items:
Transformation costs






2

Earn-out adjustments







(7)
Global Products product quality costs







33
Adjusted segment EBITA
(non-GAAP)
$ 390
$ 373
$ 136
$ 89
$ 79
$ 54
$ 343
$ 316
Adjusted segment EBITA Margin %
(non-GAAP)
13.4 %
13.6 %
12.5 %
8.4 %
14.6 %
11.0 %
30.3 %
24.3 %
Six Months Ended March 31,
(in millions)
Building Solutions
North America
Building Solutions
EMEA/LA
Building Solutions
Asia Pacific
Global Products
2025
2024
2025
2024
2025
2024
2025
2024
Sales
$ 5,660
$ 5,226
$ 2,158
$ 2,102
$ 1,069
$ 998
$ 2,215
$ 2,480
Segment EBITA
$ 722
$ 658
$ 244
$ 169
$ 128
$ 100
$ 667
$ 557
Adjusting items:
Transformation costs






2

Earn-out adjustments







(7)
Global Products product quality costs







33
Adjusted segment EBITA
(non-GAAP)
$ 722
$ 658
$ 244
$ 169
$ 128
$ 100
$ 669
$ 583
Adjusted segment EBITA Margin %
(non-GAAP)
12.8 %
12.6 %
11.3 %
8.0 %
12.0 %
10.0 %
30.2 %
23.5 %
The following table reconciles Corporate expense from continuing operations as reported to the comparable adjusted amounts (unaudited):
Three Months Ended March 31,
Six Months Ended March 31,
(in millions)
2025
2024
2025
2024
Corporate expense (GAAP)
$ 186
$ 92
$ 357
$ 231
.
Adjusting items:
Transaction/separation costs
(7)
(5)
(18)
(5)
Transformation costs
(44)

(77)

Cyber incident costs

(4)
(27)
Adjusted corporate expense (non-GAAP)
$ 135
$ 83
$ 262
$ 199
6. Net Income and Diluted Earnings Per Share
The following tables reconcile income from continuing operations attributable to JCI and diluted earnings per share from continuing operations as reported to the comparable adjusted amounts (unaudited):
Three Months Ended March 31,
Income from continuing
operations attributable to JCI
Diluted earnings
per share
(in millions, except per share)
2025
2024
2025
2024
As reported (GAAP)
$ 473
$ (321)
$ 0.71
$ (0.47)
Adjusting items:
Net mark-to-market adjustments
13
(15)
0.02
(0.02)
Earn-out adjustments

(7)

(0.01)
Restructuring and impairment costs, net of NCI
62
239
0.09
0.35
Water systems AFFF settlement

750

1.10
Water systems AFFF insurance recoveries
(8)

(0.01)

Global Products product quality costs

33

0.05
Transaction/separation costs
7
5
0.01
0.01
Transformation costs
46

0.07

Cyber incident costs

4

0.01
Discrete tax items
(36)

(0.05)

Related tax impact
(12)
(217)
(0.02)
(0.32)
Adjusted (non-GAAP)*
$ 545
$ 471
$ 0.82
$ 0.69
* May not sum due to rounding
Six Months Ended March 31,
Income from continuing
operations attributable to JCI
Diluted earnings
per share
(in millions, except per share)
2025
2024
2025
2024
As reported (GAAP)
$ 836
$ 19
$ 1.26
$ 0.03
Adjusting items:
Net mark-to-market adjustments
14
(37)
0.02
(0.05)
Earn-out adjustments

(7)

(0.01)
Restructuring and impairment costs, net of NCI
95
274
0.14
0.40
Water systems AFFF settlement

750

1.10
Water systems AFFF insurance recoveries
(12)

(0.02)

Global Products product quality issue

33

0.05
Transaction/separation costs
18
5
0.03
0.01
Transformation costs
79

0.12

Cyber incident costs

27

0.04
Discrete tax items
(36)
(57)
(0.05)
(0.08)
Related tax impact
(23)
(221)
(0.03)
(0.32)
Adjusted (non-GAAP)*
$ 971
$ 786
$ 1.46
$ 1.15
* May not sum due to rounding
The following table reconciles the denominators used to calculate basic and diluted earnings per share (in millions; unaudited):
Three Months Ended March
31,
Six Months Ended March
31,
2025
2024
2025
2024
Weighted average shares outstanding
Basic weighted average shares outstanding
659.1
679
$ 660.6
$ 679.9
Effect of dilutive securities:
Stock options, unvested restricted stock and unvested
performance share awards
1.9

2.4
1.6
Diluted weighted average shares outstanding
661.0
679.0
663.0
681.5
For the three months ended March 31, 2024, the total number of potential dilutive shares due to stock options, unvested restricted stock and unvested performance share awards was 1.6 million. However, these items were not included in the computation of diluted loss per share for the three months ended March 31, 2024 since to do so would decrease the loss per share.
7. Debt Ratios
The following table includes continuing operations and details net debt to income before income taxes and net debt to adjusted EBITDA (unaudited):
(in millions)
March 31, 2025
December 31, 2024
March 31, 2024
Short-term debt
$ 1,261
$ 882
$ 2,210
Current portion of long-term debt
558
522
1,165
Long-term debt
8,167
8,589
7,348
Total debt
9,986
9,993
10,723
Less: cash and cash equivalents
795
1,237
838
Net debt
$ 9,191
$ 8,756
$ 9,885
Last twelve months income before income taxes
$ 2,582
$ 1,610
$ 811
Net debt to income before income taxes
3.6x
5.4x
12.2x
Last twelve months adjusted EBITDA (non-GAAP)
$ 3,779
$ 3,733
$ 3,423
Net debt to adjusted EBITDA (non-GAAP)
2.4x
2.3x
2.9x
The following table reconciles income from continuing operations to adjusted EBIT and adjusted EBITDA (unaudited):
Twelve Months Ended
(in millions)
March 31, 2025
December 31, 2024
March 31, 2024
Income from continuing operations
$ 2,225
$ 1,432
$ 1,457
Income tax provision (benefit)
357
178
(646)
Income before income taxes
2,582
1,610
811
Net financing charges
332
341
306
EBIT
2,914
1,951
1,117
Adjusting items:
Net mark-to-market adjustments
4
(24)
57
Restructuring and impairment costs
330
507
565
Water systems AFFF settlement

750
750
Water systems AFFF insurance recoveries
(379)
(371)

Earn-out adjustments
(61)
(68)
(7)
Transaction/separation costs
45
43
68
Transformation costs
79
33

Cyber incident costs

4
27
Global Products product quality costs

33
33
Loss on divestiture
42
42

EMEA/LA joint venture loss
17
17

Adjusted EBIT (non-GAAP)
2,991
2,917
2,610
Depreciation and amortization
788
816
813
Adjusted EBITDA (non-GAAP)
$ 3,779
$ 3,733
$ 3,423
8. Income Taxes
The Company's effective tax rate before consideration of certain excluded items was approximately 12.0% for the three and six months ending March 31, 2025 and 11.9% and 11.7% for the three and six months ending March 31, 2024, respectively.
Johnson Controls Logo. (PRNewsFoto/JOHNSON CONTROLS, INC.) (PRNewsFoto/)
Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson-controls-reports-strong-q2-results-raises-fy25-guidance-302447970.html
SOURCE Johnson Controls International plc

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lead Plaintiff Deadline is June 16, 2025 for Investors of Ibotta, Inc.
Lead Plaintiff Deadline is June 16, 2025 for Investors of Ibotta, Inc.

Associated Press

timean hour ago

  • Associated Press

Lead Plaintiff Deadline is June 16, 2025 for Investors of Ibotta, Inc.

NEW YORK, NY - June 8, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ibotta, Inc. ('Ibotta' or the 'Company') (NYSE: IBTA) on behalf of Ibotta investors. CLICK HERE TO JOIN THE CASE If you are an investor in Ibotta and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003. DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than June 16, 2025 to serve as a lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery. Ibotta purports to be a technology company that allows consumer packaged goods brands to deliver digital promotions to consumers through the Ibotta Performance Network. On April 18, 2024, Ibotta conducted its Initial Public Offering ('IPO'), offering 6,560,700 million shares of Class A common stock at a price of $88 per share. The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that; (i) Ibotta's data measurement system did not provide accurate, precise, and real time client campaign and consumer data measurement; (ii) the Company's business mix had shifted and was generating less revenue; and (iii) Ibotta had 'exhausted' its clients' budgets, negatively impacting fourth quarter 2024 revenue and expected first quarter 2025 revenue. According to the action, on February 26, 2025, after market hours, in connection with reporting fourth quarter 2024 and full year 2024 financial results, Ibotta's CEO Bryan W. Leach ('CEO Leach') explained just how deficient Ibotta's data measurement technology was by stating that 'it has become clear that we need to bring to market a more rigorous form of measurement that goes beyond the industry standard return on ad spend, or ROAS, framework.' Further CEO Leach allegedly announced that Ibotta would transform into a programmatic advertising company, which according to the complaint demonstrates that, at the time of the IPO, Ibotta's data measurement infrastructure was not suited for heavy reliance on third party platforms. On this news, the price of Ibotta's stock fell $29.08, or nearly 46%, to close at $34.09 on February 27, 2025, more than 60% lower than the IPO price of $88 per share. WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT: Pamela A. Mayer KAPLAN FOX & KILSHEIMER LLP 800 Third Avenue, 38th Floor New York, New York 10022 (646) 315-9003 [email protected] Laurence D. King KAPLAN FOX & KILSHEIMER LLP 1999 Harrison Street, Suite 1560 Oakland, California 94612 (415) 772-4704 [email protected] Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. View the original release on

This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space
This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space

Yahoo

time3 hours ago

  • Yahoo

This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space

Hims & Hers is gaining market share in the telehealth sector and has a long runway to disrupt the healthcare industry. It is acquiring a company in order to enter Europe. The stock is expensive, but it may still be a great investment over the long term. 10 stocks we like better than Hims & Hers Health › Telehealth has gone through a major boom-and-bust cycle. One promising stock emerging from the bust is Hims & Hers (NYSE: HIMS). Through nifty marketing and an insurance-circumventing subscription model that delivers medicine directly to your front door, the company is taking a lot of share in the telehealth market. The stock has traded up 449% since going public, and it is up a staggering 158% in the past year. Disruptive innovation helped bring shareholders of Hims & Hers stock major gains. But does that make the stock a buy today? People in the United States get frustrated dealing with health insurance -- as you may know from personal experience. Hims & Hers aims to slowly disrupt the market with an innovative approach that bypasses insurers. It helps customers easily get generic medications that help deal with sexual health, hair loss, mental health, and other common concerns, by having prescriptions and shipments sent straight to their doors through monthly subscriptions. This model has helped Hims & Hers dominate the telehealth prescription market and reach $1.78 billion in trailing-12-month revenue. It's now trying to further expand its offerings by adding the branded weight loss drug Wegovy to its marketplace through a partnership with Novo Nordisk (NYSE: NVO). Previously, Hims & Hers sold weight loss drugs under an exemption because of supply shortages for the products, but with those shortages now resolved, it has to work with patent holders such as Novo Nordisk. Along with weight loss, it's also aiming to get into testosterone and menopause-related prescriptions. Today, Hims & Hers has 2.4 million active customers. Management believes there are over 100 million people who could utilize one of its products, giving the company a huge runway to grow. A key factor will be the new partnership for marketing Wegovy, which is an expensive subscription at an introductory discount offer of $549 a month. Usage of such drugs is growing like a weed, and could be a new growth avenue for Hims & Hers to pursue. Another huge step for Hims & Hers is international expansion. While countries vary in their approaches to healthcare and insurance, most people want easy-to-use products, affordable prices, and convenient at-home shipping regardless of where they live. Management hopes to supercharge international growth with its proposed buyout of competitor Zava in Europe. Zava serves the western European market with 1.3 million active customers in the United Kingdom, France, Germany, and Ireland. The combined company can utilize Hims & Hers' marketing expertise, increasing scale, and partnerships to bring this sought-after model to Europe. Global disruption of the healthcare space will give Hims & Hers an even larger runway for growth, while also allowing it to invest in new innovations -- including at-home patient testing and its own compounding manufacturing facility. Hims & Hers has grand ambitions to disrupt healthcare with its direct-to-consumer model, and Zava will give it even more scale to keep accelerating growth. It will be exciting to see what the combined company can do over the next decade. You can feel the excitement with Hims & Hers and its explosive revenue growth. Sales grew 111% year over year last quarter, and are expected to hit at least $2.3 billion in 2025. (They were just $100 million in 2020.) The company has a goal of reaching $6.5 billion in sales by 2030, which would make it one of the fastest-growing companies in the world this decade. This fast growth has created some high expectations for Hims & Hers stock. It now has a price-to-earnings ratio (P/E) of 79, which is a high trailing earnings multiple even for a fast-growing company. However, revenue is growing so quickly and with such high margins that the company may grow into this high valuation by the end of the decade. As noted, management has a goal of $6.5 billion in revenue in 2030. With 20% bottom-line profit margins -- easily doable with 77% gross profit margin over the last 12 months -- that would equate to roughly $1.3 billion in annual earnings in 2030. Today, the market cap is $12.3 billion, which would mean a P/E of just around 9.5 by 2030 if the market cap did not change (which is an unlikely scenario, but demonstrates that there is potential for the valuation to drop). Even with some shareholder dilution that raises the number of shares outstanding, the stock would be trading at a P/E of around 10 to 12 at the current share price (which is also likely to change). If you believe this rapid growth will continue over the long term, Hims & Hers stock will grow into its valuation. If you have any doubts about this pace of growth, shares should be considered overvalued at the moment. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor's total average return is 997% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Brett Schafer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space was originally published by The Motley Fool

BF-A, BF-B Investors Have Opportunity to Join Brown-Forman Corporation Fraud Investigation with the Schall Law Firm
BF-A, BF-B Investors Have Opportunity to Join Brown-Forman Corporation Fraud Investigation with the Schall Law Firm

Business Wire

time17 hours ago

  • Business Wire

BF-A, BF-B Investors Have Opportunity to Join Brown-Forman Corporation Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Brown-Forman Corporation ('Brown-Forman' or 'the Company') (NYSE: BF-A, BF-B) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Brown-Forman reported its financial results for fiscal year 2025 on June 5, 2025. The Company reported a decline in year-over-year sales of 7.3% and earnings per share below consensus estimates. The Company stated its "results did not meet our long-term growth aspirations," and advised investors that "looking ahead to fiscal 2026, we expect continued headwinds." If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store